Water-soluble rifamycin derivs. - prepd. by reacting rifamycin-sv hydrazone, aryl hydrazone or oxime derivs. with alkali salts of aliphatic, aromatic or steroid acids

New water-soluble rifamycins are cpds. of formula R.An (where R is the molecule of the hydrazone, arylhydrazone or oxime of rifamycin SV A is the molecule of the alkaline salt of 1-16C straight-chain or brached aliphatic organic acid, an opt. nuclear-substd. aromatic acid, or an acid with steroid st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SAUCIUC,ALEXANDRU, DIACONESCU,CONSTANTIN, PAUNESCU,EUGENIU,DR, ALBU,MARGARETA, NITELEA,ION
Format: Patent
Sprache:eng ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SAUCIUC,ALEXANDRU
DIACONESCU,CONSTANTIN
PAUNESCU,EUGENIU,DR
ALBU,MARGARETA
NITELEA,ION
description New water-soluble rifamycins are cpds. of formula R.An (where R is the molecule of the hydrazone, arylhydrazone or oxime of rifamycin SV A is the molecule of the alkaline salt of 1-16C straight-chain or brached aliphatic organic acid, an opt. nuclear-substd. aromatic acid, or an acid with steroid structure; and n = 0.5-5). (I) are amorphous or macrocrystalline, orange to dark red/brown substances which are very soluble inhalogenated hydrocarbons, soluble in water and lower aliphatic alcohols, and poorly soluble in aliphatic hydrocarbons. Rifamycin derivs. have antibacterial (esp. antitubercular), antiviral, immunosuppressant and antileukaemic activity. The solubility properties of (I) means that in testing, solvents such as dimethyl sulphoxide or detergents are not needed, so that falsification of results due to solvent or detergents are avoided. In therapeutic nitrations, the good solubility properties reduces the risk of liver damage arising from hepato-biliary circulation of the zifamycin deriv.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE2728868A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE2728868A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE2728868A13</originalsourceid><addsrcrecordid>eNqNjkEKwjAURLtxIeod_gFswQrarWjFAwgu5Tf5tR_TJuTHaj2Q59SC2K2rmYE3w4yj1wkD-VisuRWGwHOJdae4AU2eW0kgBufJ6QSKDjyhCtxcBiyWFqpOe3zahuaAvjNDBuvBPrim39idQwVormgYBE0QsOUns6swsOr7tu5d35TPL8saULGWaTQq0QjNvjqJYJ8ft4eYnD2TOFTUUDjv8nSdZtkq2yyWfyBvXcZWgg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Water-soluble rifamycin derivs. - prepd. by reacting rifamycin-sv hydrazone, aryl hydrazone or oxime derivs. with alkali salts of aliphatic, aromatic or steroid acids</title><source>esp@cenet</source><creator>SAUCIUC,ALEXANDRU ; DIACONESCU,CONSTANTIN ; PAUNESCU,EUGENIU,DR ; ALBU,MARGARETA ; NITELEA,ION</creator><creatorcontrib>SAUCIUC,ALEXANDRU ; DIACONESCU,CONSTANTIN ; PAUNESCU,EUGENIU,DR ; ALBU,MARGARETA ; NITELEA,ION</creatorcontrib><description>New water-soluble rifamycins are cpds. of formula R.An (where R is the molecule of the hydrazone, arylhydrazone or oxime of rifamycin SV A is the molecule of the alkaline salt of 1-16C straight-chain or brached aliphatic organic acid, an opt. nuclear-substd. aromatic acid, or an acid with steroid structure; and n = 0.5-5). (I) are amorphous or macrocrystalline, orange to dark red/brown substances which are very soluble inhalogenated hydrocarbons, soluble in water and lower aliphatic alcohols, and poorly soluble in aliphatic hydrocarbons. Rifamycin derivs. have antibacterial (esp. antitubercular), antiviral, immunosuppressant and antileukaemic activity. The solubility properties of (I) means that in testing, solvents such as dimethyl sulphoxide or detergents are not needed, so that falsification of results due to solvent or detergents are avoided. In therapeutic nitrations, the good solubility properties reduces the risk of liver damage arising from hepato-biliary circulation of the zifamycin deriv.</description><edition>2</edition><language>eng ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>1978</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19780511&amp;DB=EPODOC&amp;CC=DE&amp;NR=2728868A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19780511&amp;DB=EPODOC&amp;CC=DE&amp;NR=2728868A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAUCIUC,ALEXANDRU</creatorcontrib><creatorcontrib>DIACONESCU,CONSTANTIN</creatorcontrib><creatorcontrib>PAUNESCU,EUGENIU,DR</creatorcontrib><creatorcontrib>ALBU,MARGARETA</creatorcontrib><creatorcontrib>NITELEA,ION</creatorcontrib><title>Water-soluble rifamycin derivs. - prepd. by reacting rifamycin-sv hydrazone, aryl hydrazone or oxime derivs. with alkali salts of aliphatic, aromatic or steroid acids</title><description>New water-soluble rifamycins are cpds. of formula R.An (where R is the molecule of the hydrazone, arylhydrazone or oxime of rifamycin SV A is the molecule of the alkaline salt of 1-16C straight-chain or brached aliphatic organic acid, an opt. nuclear-substd. aromatic acid, or an acid with steroid structure; and n = 0.5-5). (I) are amorphous or macrocrystalline, orange to dark red/brown substances which are very soluble inhalogenated hydrocarbons, soluble in water and lower aliphatic alcohols, and poorly soluble in aliphatic hydrocarbons. Rifamycin derivs. have antibacterial (esp. antitubercular), antiviral, immunosuppressant and antileukaemic activity. The solubility properties of (I) means that in testing, solvents such as dimethyl sulphoxide or detergents are not needed, so that falsification of results due to solvent or detergents are avoided. In therapeutic nitrations, the good solubility properties reduces the risk of liver damage arising from hepato-biliary circulation of the zifamycin deriv.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1978</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjkEKwjAURLtxIeod_gFswQrarWjFAwgu5Tf5tR_TJuTHaj2Q59SC2K2rmYE3w4yj1wkD-VisuRWGwHOJdae4AU2eW0kgBufJ6QSKDjyhCtxcBiyWFqpOe3zahuaAvjNDBuvBPrim39idQwVormgYBE0QsOUns6swsOr7tu5d35TPL8saULGWaTQq0QjNvjqJYJ8ft4eYnD2TOFTUUDjv8nSdZtkq2yyWfyBvXcZWgg</recordid><startdate>19780511</startdate><enddate>19780511</enddate><creator>SAUCIUC,ALEXANDRU</creator><creator>DIACONESCU,CONSTANTIN</creator><creator>PAUNESCU,EUGENIU,DR</creator><creator>ALBU,MARGARETA</creator><creator>NITELEA,ION</creator><scope>EVB</scope></search><sort><creationdate>19780511</creationdate><title>Water-soluble rifamycin derivs. - prepd. by reacting rifamycin-sv hydrazone, aryl hydrazone or oxime derivs. with alkali salts of aliphatic, aromatic or steroid acids</title><author>SAUCIUC,ALEXANDRU ; DIACONESCU,CONSTANTIN ; PAUNESCU,EUGENIU,DR ; ALBU,MARGARETA ; NITELEA,ION</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE2728868A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; ger</language><creationdate>1978</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>SAUCIUC,ALEXANDRU</creatorcontrib><creatorcontrib>DIACONESCU,CONSTANTIN</creatorcontrib><creatorcontrib>PAUNESCU,EUGENIU,DR</creatorcontrib><creatorcontrib>ALBU,MARGARETA</creatorcontrib><creatorcontrib>NITELEA,ION</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAUCIUC,ALEXANDRU</au><au>DIACONESCU,CONSTANTIN</au><au>PAUNESCU,EUGENIU,DR</au><au>ALBU,MARGARETA</au><au>NITELEA,ION</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Water-soluble rifamycin derivs. - prepd. by reacting rifamycin-sv hydrazone, aryl hydrazone or oxime derivs. with alkali salts of aliphatic, aromatic or steroid acids</title><date>1978-05-11</date><risdate>1978</risdate><abstract>New water-soluble rifamycins are cpds. of formula R.An (where R is the molecule of the hydrazone, arylhydrazone or oxime of rifamycin SV A is the molecule of the alkaline salt of 1-16C straight-chain or brached aliphatic organic acid, an opt. nuclear-substd. aromatic acid, or an acid with steroid structure; and n = 0.5-5). (I) are amorphous or macrocrystalline, orange to dark red/brown substances which are very soluble inhalogenated hydrocarbons, soluble in water and lower aliphatic alcohols, and poorly soluble in aliphatic hydrocarbons. Rifamycin derivs. have antibacterial (esp. antitubercular), antiviral, immunosuppressant and antileukaemic activity. The solubility properties of (I) means that in testing, solvents such as dimethyl sulphoxide or detergents are not needed, so that falsification of results due to solvent or detergents are avoided. In therapeutic nitrations, the good solubility properties reduces the risk of liver damage arising from hepato-biliary circulation of the zifamycin deriv.</abstract><edition>2</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; ger
recordid cdi_epo_espacenet_DE2728868A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title Water-soluble rifamycin derivs. - prepd. by reacting rifamycin-sv hydrazone, aryl hydrazone or oxime derivs. with alkali salts of aliphatic, aromatic or steroid acids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A23%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAUCIUC,ALEXANDRU&rft.date=1978-05-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE2728868A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true